Active	Status	Sponsor type	Region	Phase	Filter
6 Active 6 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Narita, Ichiei
EAGLE, NCT03749447 / 2018-003253-24: An Extended Access Program for Bardoxolone Methyl in Patients With CKD	Terminated	3	270	Europe, Japan, US, RoW	Bardoxolone methyl, RTA 402	Biogen, Reata Pharmaceuticals, Inc.	Chronic Kidney Diseases, Alport Syndrome, Autosomal Dominant Polycystic Kidney	08/23	08/23
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
Okumura, Takahiro
EMPA-AHF, NCT05392764: Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure	Recruiting	3	524	Japan	Empagliflozin 10 MG, Placebo	Juntendo University, Boehringer Ingelheim	Acute Heart Failure	03/25	12/27
Uchida, Hieoo
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Narita, Ichiei
EAGLE, NCT03749447 / 2018-003253-24: An Extended Access Program for Bardoxolone Methyl in Patients With CKD	Terminated	3	270	Europe, Japan, US, RoW	Bardoxolone methyl, RTA 402	Biogen, Reata Pharmaceuticals, Inc.	Chronic Kidney Diseases, Alport Syndrome, Autosomal Dominant Polycystic Kidney	08/23	08/23
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
Okumura, Takahiro
EMPA-AHF, NCT05392764: Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure	Recruiting	3	524	Japan	Empagliflozin 10 MG, Placebo	Juntendo University, Boehringer Ingelheim	Acute Heart Failure	03/25	12/27
Uchida, Hieoo
No trials found